This week, the U.S. House of Representatives is expected to consider a budget resolution that could lead to devastating cuts to Medicaid. Ahead of the vote, the American Cancer Society Cancer Action Network (ACS CAN) is urging House members to oppose cuts to Medicaid.
Washington, D.C. - Last night, the Solicitor General’s office filed its merits brief in the U.S. Supreme Court case of Braidwood Management v.
A broad coalition of patient organizations today issued the following statement in response to cuts in staff, and research funding at federal agencies vital for American health.
Today, the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act was introduced in the United States House of Representatives by Representatives Neal Dunn, M.D. (R-FL) and Yvette Clarke (D-NY) with Representatives Greg Murphy (R-NC) and Troy Carter (D-LA) as cosponsors.
Today, the House Budget Committee began to mark up their budget resolution for Fiscal Year 2025.
The administration released an executive order to significantly reduce the federal workforce. Together with other executive actions to date, cancer research and innovation are at risk.
The Senate Budget Committee is scheduled to mark up its budget resolution this week, setting the stage for significant cuts in discretionary spending to offset the cost of the package.
A bill introduced in the House and Senate last week aims to improve future equitable access to new and innovative cancer screenings among Medicare beneficiaries in order to increase early detection of more cancers for more individuals.
Bipartisan legislation that would remove financial barriers to prostate cancer screening was introduced today in the U.S. Senate. Sponsored by Senators John Boozman (R-AR) and Cory Booker (D-NJ), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements such as deductibles, copayments and coinsurance, for prostate cancer screening tests for men with the highest risk of prostate cancer, including Black men and those with a family history of the disease.